Physician
Dayton Physicians, LLC
Dayton Physicians, LLC was paid $3.09M by Medicaid between Jan 2018 and Nov 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoDAYTON PHYSICIANS, LLC
DAYTON, OH 45409
DAYTON, OH 45409
33aNPI1902844947assigned 06/03/2006
33bProvider typeHematology & Oncology Physician
28Total paid$3.09M
24GClaims72,375
24DCodes billed37
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Ohio
Rank by total paid#2 of 27
Median peer was paid$13K
This provider vs. median229×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,952 | $484K | |
| 2019 | 10,755 | $425K | |
| 2020 | 10,149 | $562K | |
| 2021 | 10,918 | $479K | |
| 2022 | 10,259 | $441K | |
| 2023 | 9,611 | $419K | |
| 2024incomplete | 7,731 | $275K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 27,382 | 22,015 | $1.11M |
| 77014 | 26% | 12,795 | 5,727 | $788K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 10% | 5,111 | 3,433 | $317K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 9,968 | 9,009 | $285K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.2% | 3,274 | 2,456 | $161K |
| 77386 | 4.1% | 478 | 193 | $127K | |
| 77412 | 3.4% | 828 | 427 | $106K | |
| 77427 | 2.0% | 754 | 478 | $61K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,331 | 926 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 542 | 328 | $19K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | <1% | 248 | 87 | $18K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 246 | 222 | $16K |
25 more codes
| 77334 | <1% | 46 | $13K | |
| 81003 | <1% | 6,069 | $8K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 269 | $6K |
| 77336 | <1% | 186 | $6K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 131 | $4K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 78 | $3K |
| J0185 | Injection, aprepitant, 1 mg | <1% | 19 | $3K |
| 51798 | <1% | 341 | $3K | |
| 96367 | <1% | 105 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 223 | $2K |
| 52000 | <1% | 14 | $1K | |
| 99243 | <1% | 21 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 42 | $1K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 20 | $828.16 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $606.50 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 46 | $521.24 |
| 99205 | Prolong outpt/office vis | <1% | 12 | $464.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 456 | $392.15 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,157 | $368.66 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13 | $116.82 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 24 | $7.36 |
| 1036F | 0% | 15 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 15 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 73 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSERGENT, BRENDA (CREDENTIALING SPECIALIST)